Developer docs
API playgroundTry for free, no card

Search company profiles

AgPlenus

Full company profile

uuid0007g6j

Namestring
AgPlenus
Legal namestring
Ag Plenus Ltd.
Websiteurl
agplenus.com
Company typeenum
Private
Founded yearint
2018
Descriptiontext

AgPlenus is an Israel-based computational crop protection discovery company and a wholly-owned subsidiary of Evogene Ltd. (NASDAQ: EVGN), established in November 2018 as a spin-out of Evogene's ag-chemical activities that had been underway since 2014. Headquartered in Rehovot (13 Gad Feinstein St., Park Rehovot), the company employs 11–50 staff and is led by CEO Dan Gelvan PhD, with Ofer Haviv (Evogene President and CEO) serving as Chairman of the Board. Its mission is to address the long-standing innovation gap in crop protection — particularly the absence of new herbicide modes of action over the past three decades — by applying AI to discover target-based, resistance-breaking chemistry for farmers worldwide.

The company's core technology is the ChemPass AI for Ag™ platform, which combines computational chemistry with experimental biology from target selection through greenhouse and field validation. Proprietary sub-modules include TargetSelector™ (novel druggable target protein identification), PointHit™ (deep-docking high-throughput virtual screening of billions of compounds), and a generative de novo molecular design tool. AgPlenus operates three product verticals — weed control (herbicides), disease control (fungicides), and insect control (insecticides) — with disclosed pipeline assets APTH-1 (herbicide, formerly under Bayer), APCO-12 (herbicide, under Corteva), APH1 (herbicide lead-stage with demonstrated 70–100% field efficacy against six of nine commercial weed species including glyphosate-resistant strains), and APTF-1/APTF-2/APTF-3 (fungicides targeting wheat blotch and other resistant diseases). The platform's intellectual property includes a pending patent application on the APH1 herbicide candidate.

AgPlenus operates as an exclusively B2B platform licensing business with no direct product sales. Revenue is generated through strategic licensing and collaboration agreements with global agrochemical corporations, providing upfront fees, ongoing research funding, milestone payments, and royalties on future sales. Active named partners are Corteva Agriscience (multi-year, ongoing since March 2020; APCO-12 exclusive commercialization license) and, until termination in 2025/2026, Bayer AG (APTH1 exclusive license, ended after the target failed to meet product criteria). Minor historical partners include BASF and ICL Group, and the company works with CROs such as SynTech Research for independent field validation. The company has no independent external investors or standalone funding rounds; any financing flows through parent Evogene, which reported $13.1M consolidated cash as of Q1 2026 following a $3.4M warrant exercise in February 2026.

Short descriptiontext

AgPlenus is an Israel-based, AI-driven crop protection discovery subsidiary of Evogene Ltd. (NASDAQ: EVGN) that uses its ChemPass AI for Ag™ platform to identify novel modes of action for herbicides, fungicides, and insecticides, licensing candidates exclusively to agrochemical partners.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersRehovot, Israel
HQ citystring
Rehovot
HQ countrystring
Israel
HQ regionstring
Middle East
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
computational crop protection, AI-driven herbicide discovery, agrochemical licensing platform, novel mode of action, virtual screening molecules
Industry1 code
PRIMARYAFABAMAI
Pest/Disease/Weed Detection & Forecasting Analytics
Agriculture & Food Production/Agricultural Inputs & Agrochemicals/Precision Agriculture Solutions (Sensors & Data Analytics)
NAICS code2 codes
  • Pesticide, Fertilizer, and Other Agricultural Chemical Manufacturing3253
  • Pesticide and Other Agricultural Chemical Manufacturing325320
SIC code1 code
  • Agricultural Chemicals2870
Product category
Agrochemical / Crop Protection Discovery Software
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Licensing & Royalty Revenue
TypeLicensing Royalties
Description

AgPlenus licenses its proprietary computational technology and receives upfront payments, ongoing research funding, milestone payments, and royalties based on future product sales from collaboration partners (Bayer, Corteva). This represents the primary revenue mechanism.

2Strategic Partnership Funding
TypeSubscription Recurring
Description

Parent company Evogene receives research funding through collaborations. Evogene consolidated cash of $13.1 million (Q1 2026) following warrant exercise. AgPlenus assets reverted from terminated Bayer herbicide collaboration after target protein failed to meet product criteria.

stocktitan.net
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

AgPlenus operates a target-based crop protection discovery platform that combines its proprietary ChemPass AI for Ag™ computational engine with experimental biology and chemistry. The company identifies novel druggable target proteins and runs massive parallel virtual screening of billions of molecules to discover new modes-of-action (MoA) herbicides, fungicides, and insecticides that break resistance. Resulting product candidates are then commercialized through exclusive licensing agreements with multinational agrochemical partners such as Bayer and Corteva.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • APH1 herbicide candidate demonstrated 70%-100% weed control in 6 out of 9 commercially important weed species at commercial dose rates in independent field tests
+3 more records
Product overview1 text field

AgPlenus operates as a platform company combining the ChemPass AI for Ag™ computational engine with experimental validation capabilities. The core product offerings span three crop protection categories: Weed Control (Herbicides), Disease Control (Fungicides), and Insect Control (Insecticides). Supporting the platform are specialized tools including TargetSelector™ for target protein identification, PointHit™ for high-throughput virtual screening, and a de novo molecular design tool. The development pipeline includes herbicide candidates APTH-1 (Bayer collaboration) and APCO-12 (Corteva collaboration), along with fungicide candidates APTF-1, APTF-2, and APTF-3. The company employs a target-based approach addressing resistance from the start, mapping and selecting novel Modes of Action (MoAs), with one integrated platform serving diverse crop protection indications.

Product and service2 records
1ChemPass AI for Ag™
CategoryComputational Discovery Platform
Description

Proprietary AI-driven computational platform enabling discovery of novel druggable target proteins, virtual screening of billions of compounds, identification and optimization of small molecule inhibitors, and de novo molecule design for crop protection applications. Sold/licensed to agrochemical partners as the foundation of AgPlenus' target-based discovery offering.

2Weed Control (Herbicides)
Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierMinorTypeOthersAnnounced on2024-02-22
Description

Agricultural R&D contract research organization located in California that conducted independent field tests confirming APH1 herbicide candidate efficacy against weeds at commercial application rates.

Strategic tierCoreTypeOEM/ Whitelabel/ Licensing PartnerAnnounced on2024-02-21
Description

Licensing & collaboration agreement for development of novel sustainable broad-spectrum herbicide targeting APTH1 protein. Bayer has exclusive license for development and commercialization. AgPlenus uses its AI-driven computational technology to design and optimize molecules. Agreement includes upfront payment, research funding, milestone payments, and royalties on future product sales. Collaboration terminated in 2026 after target protein failed to meet product criteria, with assets reverting to AgPlenus.

3Corteva Agriscience
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2020-03-25
Description

Multi-year collaboration for development of novel herbicides addressing global weed resistance. Corteva applies its crop protection R&D expertise while AgPlenus applies its computational platform to optimize chemical families already validated for herbicidal activity through new MoAs. Corteva holds exclusive license to commercialize resulting herbicides. Achieved milestone of identifying novel MoA class APCO-12. Collaboration ongoing as of Q1 2026.

agplenus.com
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2018-11-19
Description

Existing ag-chemical collaboration transferred to AgPlenus from parent company Evogene. AgPlenus maintains ongoing collaborations with industry leaders including BASF for development of next-generation agrochemical products.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2018-11-19
Description

Original ag-chemical collaboration transferred from Evogene to AgPlenus. ICL is a global specialty minerals and chemicals company. The nature of collaboration relates to ag-chemical product development.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Biotalys is a Belgium-based agricultural biotech developing protein-based biocontrol solutions (e.g., AGROBODY™ platform) for crop protection, also addressing resistance challenges via novel modes of action. Direct peer given shared focus on AI/biotech-driven discovery of novel crop protection agents, B2B licensing model, and similar indication focus on fungicides and insecticides.

TypeEmerging player
Description

Pairwise uses base editing and proprietary gene-editing tools to develop improved crops and novel plant traits for agriculture. Comparable to AgPlenus as a platform-driven agricultural biotech leveraging proprietary technology to license novel crop innovations to industry players.

TypeEmerging player
Description

Inari combines AI-driven predictive design with multiplex gene editing to develop next-generation seeds. Similar platform-based B2B model licensing novel agricultural innovations, with comparable customer profile of major seed and crop protection companies.

TypeEmerging player
Description

Pivot Bio develops microbial nitrogen-fixing crop inputs using AI and synthetic biology, addressing fertilizer efficiency and sustainability. Comparable as a platform-driven agricultural biotech pursuing licensing and partnership-driven commercialization with major ag-input companies.

TypeEmerging player
Description

Benson Hill applies AI/ML and genomics to crop improvement via its CropOS™ platform, licensing improved seed varieties. Comparable technology stack (AI + biological data) and B2B go-to-market targeting major agribusiness customers.

TypeEmerging player
Description

Sound Agriculture develops on-demand crop solutions (e.g., SOURCE™ nitrogen-fixing microbes) using a discovery platform combining chemistry and biology. Comparable as a discovery-platform company addressing crop input innovation through novel biological/chemical modes of action.

TypeEmerging player
Description

Tropic Biosciences uses gene editing (GEiGS®) to develop improved tropical crops and address crop disease. Comparable platform-company model targeting crop protection and agricultural productivity through novel biotechnology approaches.

TypeDirect peer
Description

Computomics is a Germany-based computational biology company applying AI/machine learning to plant breeding, microbiome analysis, and crop research. Closely comparable to AgPlenus in applying AI-driven computational analysis to agricultural molecular discovery and serving enterprise agribusiness customers.

TypeEmerging player
Description

GreenLight Biosciences develops RNA-based crop protection products (e.g., Ledprona) targeting specific insect pests. Comparable platform-driven discovery of novel crop protection agents with new modes of action, addressing resistance challenges.

TypeOthers
Description

Cibus uses its Rapid Trait Development System (RTDS®) gene-editing platform to develop improved crop traits. Adjacent agricultural biotech applying proprietary technology platforms to address crop productivity and protection challenges for enterprise agribusiness customers.

Market position
Strengths1 record

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles11 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

AgPlenus

Agrochemical / Crop Protection Discovery Softwareagplenus.com

AgPlenus is an Israel-based, AI-driven crop protection discovery subsidiary of Evogene Ltd. (NASDAQ: EVGN) that uses its ChemPass AI for Ag™ platform to identify novel modes of action for herbicides, fungicides, and insecticides, licensing candidates exclusively to agrochemical partners.

What AgPlenus does

AgPlenus is an Israel-based computational crop protection discovery company and a wholly-owned subsidiary of Evogene Ltd. (NASDAQ: EVGN), established in November 2018 as a spin-out of Evogene's ag-chemical activities that had been underway since 2014. Headquartered in Rehovot (13 Gad Feinstein St., Park Rehovot), the company employs 11–50 staff and is led by CEO Dan Gelvan PhD, with Ofer Haviv (Evogene President and CEO) serving as Chairman of the Board. Its mission is to address the long-standing innovation gap in crop protection — particularly the absence of new herbicide modes of action over the past three decades — by applying AI to discover target-based, resistance-breaking chemistry for farmers worldwide.

The company's core technology is the ChemPass AI for Ag™ platform, which combines computational chemistry with experimental biology from target selection through greenhouse and field validation. Proprietary sub-modules include TargetSelector™ (novel druggable target protein identification), PointHit™ (deep-docking high-throughput virtual screening of billions of compounds), and a generative de novo molecular design tool. AgPlenus operates three product verticals — weed control (herbicides), disease control (fungicides), and insect control (insecticides) — with disclosed pipeline assets APTH-1 (herbicide, formerly under Bayer), APCO-12 (herbicide, under Corteva), APH1 (herbicide lead-stage with demonstrated 70–100% field efficacy against six of nine commercial weed species including glyphosate-resistant strains), and APTF-1/APTF-2/APTF-3 (fungicides targeting wheat blotch and other resistant diseases). The platform's intellectual property includes a pending patent application on the APH1 herbicide candidate.

AgPlenus operates as an exclusively B2B platform licensing business with no direct product sales. Revenue is generated through strategic licensing and collaboration agreements with global agrochemical corporations, providing upfront fees, ongoing research funding, milestone payments, and royalties on future sales. Active named partners are Corteva Agriscience (multi-year, ongoing since March 2020; APCO-12 exclusive commercialization license) and, until termination in 2025/2026, Bayer AG (APTH1 exclusive license, ended after the target failed to meet product criteria). Minor historical partners include BASF and ICL Group, and the company works with CROs such as SynTech Research for independent field validation. The company has no independent external investors or standalone funding rounds; any financing flows through parent Evogene, which reported $13.1M consolidated cash as of Q1 2026 following a $3.4M warrant exercise in February 2026.

AgPlenus firmographics

Firmographics
Name
AgPlenus
Legal name
Ag Plenus Ltd.
Website
https://agplenus.com
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
11–50 employees
Short description
AgPlenus is an Israel-based, AI-driven crop protection discovery subsidiary of Evogene Ltd. (NASDAQ: EVGN) that uses its ChemPass AI for Ag™ platform to identify novel modes of action for herbicides, fungicides, and insecticides, licensing candidates exclusively to agrochemical partners.
Ownership category
akta.pro rank

AgPlenus industry classification

Industry
Product category
Agrochemical / Crop Protection Discovery Software
NAICS
Pesticide, Fertilizer, and Other Agricultural Chemical Manufacturing (3253), Pesticide and Other Agricultural Chemical Manufacturing (325320)
SIC
Agricultural Chemicals (2870)
akta.pro industry
PRIMARYAFABAMAI
Pest/Disease/Weed Detection & Forecasting Analytics
Agriculture & Food Production/Agricultural Inputs & Agrochemicals/Precision Agriculture Solutions (Sensors & Data Analytics)

Keywords

  • Computational crop protection
  • AI-driven herbicide discovery
  • Agrochemical licensing platform
  • Novel mode of action
  • Virtual screening molecules

Where AgPlenus is headquartered

Location

Headquarters

HQ city
Rehovot
HQ country
Israel
HQ region
Middle East

Offices3 records

Markets served

AgPlenus business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Licensing & Royalty Revenue: AgPlenus licenses its proprietary computational technology and receives upfront payments, ongoing research funding, milestone payments, and royalties based on future product sales from collaboration partners (Bayer, Corteva). This represents the primary revenue mechanism.
  2. Strategic Partnership Funding: Parent company Evogene receives research funding through collaborations. Evogene consolidated cash of $13.1 million (Q1 2026) following warrant exercise. AgPlenus assets reverted from terminated Bayer herbicide collaboration after target protein failed to meet product criteria.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

AgPlenus product offering

Product offering

Core offering

AgPlenus operates a target-based crop protection discovery platform that combines its proprietary ChemPass AI for Ag™ computational engine with experimental biology and chemistry. The company identifies novel druggable target proteins and runs massive parallel virtual screening of billions of molecules to discover new modes-of-action (MoA) herbicides, fungicides, and insecticides that break resistance. Resulting product candidates are then commercialized through exclusive licensing agreements with multinational agrochemical partners such as Bayer and Corteva.

Product overview

AgPlenus operates as a platform company combining the ChemPass AI for Ag™ computational engine with experimental validation capabilities. The core product offerings span three crop protection categories: Weed Control (Herbicides), Disease Control (Fungicides), and Insect Control (Insecticides). Supporting the platform are specialized tools including TargetSelector™ for target protein identification, PointHit™ for high-throughput virtual screening, and a de novo molecular design tool. The development pipeline includes herbicide candidates APTH-1 (Bayer collaboration) and APCO-12 (Corteva collaboration), along with fungicide candidates APTF-1, APTF-2, and APTF-3. The company employs a target-based approach addressing resistance from the start, mapping and selecting novel Modes of Action (MoAs), with one integrated platform serving diverse crop protection indications.

Differentiator

Problem solved

Functional benefit

Products and services

  • ChemPass AI for Ag™ Proprietary AI-driven computational platform enabling discovery of novel druggable target proteins, virtual screening of billions of compounds, identification and optimization of small molecule inhibitors, and de novo molecule design for crop protection applications. Sold/licensed to agrochemical partners as the foundation of AgPlenus' target-based discovery offering.
  • Weed Control (Herbicides)

Quantifiable outcome

  • APH1 herbicide candidate demonstrated 70%-100% weed control in 6 out of 9 commercially important weed species at commercial dose rates in independent field tests
  • +3 more outcomes

Companies that use AgPlenus

Customer profile

Named customers2 records

Segments4 records

Ideal customer profiles1 record

AgPlenus technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature4 records

AgPlenus partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered minor and core.

  • SynTech ResearchminorOthers · 22 February 2024Agricultural R&D contract research organization located in California that conducted independent field tests confirming APH1 herbicide candidate efficacy against weeds at commercial application rates.
  • Bayer AGcoreOEM/ Whitelabel/ Licensing Partner · 21 February 2024Licensing & collaboration agreement for development of novel sustainable broad-spectrum herbicide targeting APTH1 protein. Bayer has exclusive license for development and commercialization. AgPlenus uses its AI-driven computational technology to design and optimize molecules. Agreement includes upfront payment, research funding, milestone payments, and royalties on future product sales. Collaboration terminated in 2026 after target protein failed to meet product criteria, with assets reverting to AgPlenus.
  • Corteva AgrisciencecoreStrategic or Co-development Partner · 25 March 2020Multi-year collaboration for development of novel herbicides addressing global weed resistance. Corteva applies its crop protection R&D expertise while AgPlenus applies its computational platform to optimize chemical families already validated for herbicidal activity through new MoAs. Corteva holds exclusive license to commercialize resulting herbicides. Achieved milestone of identifying novel MoA class APCO-12. Collaboration ongoing as of Q1 2026.
  • BASFminorStrategic or Co-development Partner · 19 November 2018Existing ag-chemical collaboration transferred to AgPlenus from parent company Evogene. AgPlenus maintains ongoing collaborations with industry leaders including BASF for development of next-generation agrochemical products.
  • ICL GroupminorStrategic or Co-development Partner · 19 November 2018Original ag-chemical collaboration transferred from Evogene to AgPlenus. ICL is a global specialty minerals and chemicals company. The nature of collaboration relates to ag-chemical product development.

Scale indicators4 records

Recent moves7 records

Expansion highlights5 records

AgPlenus competitors and assessment

Company assessment

Direct peers

  • Biotalys: Biotalys is a Belgium-based agricultural biotech developing protein-based biocontrol solutions (e.g., AGROBODY™ platform) for crop protection, also addressing resistance challenges via novel modes of action. Direct peer given shared focus on AI/biotech-driven discovery of novel crop protection agents, B2B licensing model, and similar indication focus on fungicides and insecticides.
  • Computomics: Computomics is a Germany-based computational biology company applying AI/machine learning to plant breeding, microbiome analysis, and crop research. Closely comparable to AgPlenus in applying AI-driven computational analysis to agricultural molecular discovery and serving enterprise agribusiness customers.

Emerging players

  • Pairwise: Pairwise uses base editing and proprietary gene-editing tools to develop improved crops and novel plant traits for agriculture. Comparable to AgPlenus as a platform-driven agricultural biotech leveraging proprietary technology to license novel crop innovations to industry players.
  • Inari Agriculture: Inari combines AI-driven predictive design with multiplex gene editing to develop next-generation seeds. Similar platform-based B2B model licensing novel agricultural innovations, with comparable customer profile of major seed and crop protection companies.
  • Pivot Bio: Pivot Bio develops microbial nitrogen-fixing crop inputs using AI and synthetic biology, addressing fertilizer efficiency and sustainability. Comparable as a platform-driven agricultural biotech pursuing licensing and partnership-driven commercialization with major ag-input companies.
  • Benson Hill: Benson Hill applies AI/ML and genomics to crop improvement via its CropOS™ platform, licensing improved seed varieties. Comparable technology stack (AI + biological data) and B2B go-to-market targeting major agribusiness customers.
  • Sound Agriculture: Sound Agriculture develops on-demand crop solutions (e.g., SOURCE™ nitrogen-fixing microbes) using a discovery platform combining chemistry and biology. Comparable as a discovery-platform company addressing crop input innovation through novel biological/chemical modes of action.
  • Tropic Biosciences: Tropic Biosciences uses gene editing (GEiGS®) to develop improved tropical crops and address crop disease. Comparable platform-company model targeting crop protection and agricultural productivity through novel biotechnology approaches.
  • GreenLight Biosciences: GreenLight Biosciences develops RNA-based crop protection products (e.g., Ledprona) targeting specific insect pests. Comparable platform-driven discovery of novel crop protection agents with new modes of action, addressing resistance challenges.

Others

  • Cibus: Cibus uses its Rapid Trait Development System (RTDS®) gene-editing platform to develop improved crop traits. Adjacent agricultural biotech applying proprietary technology platforms to address crop productivity and protection challenges for enterprise agribusiness customers.

Market position

Strengths1 record

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

AgPlenus social profiles

Digital presence

AgPlenus financial estimates

Financial estimate

Revenue estimate

Valuation estimate

AgPlenus leadership team

Management profile

Number of profiles

Profiles11 records

AgPlenus funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

AgPlenus M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AgPlenus

What does AgPlenus do?

AgPlenus operates a target-based crop protection discovery platform that combines its proprietary ChemPass AI for Ag™ computational engine with experimental biology and chemistry. The company identifies novel druggable target proteins and runs massive parallel virtual screening of billions of molecules to discover new modes-of-action (MoA) herbicides, fungicides, and insecticides that break resistance. Resulting product candidates are then commercialized through exclusive licensing agreements with multinational agrochemical partners such as Bayer and Corteva.

Is AgPlenus a public or private company?

AgPlenus is a private company. It is classified as corporate owned and is currently operating.

When was AgPlenus founded?

AgPlenus was founded in 2018. It employs 11 to 50 people.

Where is AgPlenus based?

AgPlenus is headquartered in Rehovot, Israel, in the Middle East region.

How does AgPlenus make money?

Two revenue lines are on record. Licensing & Royalty Revenue is the primary driver. The others are strategic Partnership Funding.

Who are AgPlenus's main competitors?

Direct peers on record are Biotalys and Computomics. Emerging players are Pairwise, Inari Agriculture, Pivot Bio, Benson Hill, Sound Agriculture, Tropic Biosciences and GreenLight Biosciences. Cibus is listed as an others.

Does AgPlenus have an API?

No public API is recorded for AgPlenus.

What industry is AgPlenus in?

AgPlenus's product category is Agrochemical / Crop Protection Discovery Software. Its primary akta.pro industry code is AFABAMAI, Pest/Disease/Weed Detection & Forecasting Analytics. Its NAICS code is 3253 and its SIC code is 2870.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Third NewsAgPlenus Introduces Innovative AI Model to Predict Antifungal PotencyAgPlenus Ltd., a subsidiary of Evogene Ltd., unveiled its Antifungal Potency Predictor (APP), an AI model that predicts the antifungal potency of small molecules based on their chemical structures to accelerate early-stage crop protection discovery. The tool integrates with AgPlenus's existing ChemPass AI for Ag™ platform and is expected to reduce experimental testing requirements by prioritizing candidates with the highest likelihood of success before chemical synthesis. The company plans to leverage the APP to advance its internal fungicide pipeline and future predictive AI models targeting pathogens like Botrytis and Fusarium, addressing a global fungicide market valued at approximately $22 billion annually.Investing.comAgPlenus launches AI model to predict antifungal potency By Investing.comAgPlenus Ltd., a subsidiary of Evogene Ltd., announced the launch of its Antifungal Potency Predictor, a machine learning model designed to predict antifungal potency of small molecules from their chemical structures, expanding Evogene's ChemPass AI for Ag platform. The model aims to reduce experimental evaluation requirements during early discovery phases and will support the company's internal fungicide pipeline, including APTF-1 targeting Septoria Wheat Blotch, with planned expansions targeting Botrytis and Fusarium pathogens. The global fungicide market is estimated at approximately $22 billion annually.Investing.comAgPlenus launches AI model to predict antifungal potency By Investing.comAgPlenus Ltd., a subsidiary of Evogene Ltd., announced the launch of its Antifungal Potency Predictor, a machine learning model that predicts antifungal potency of small molecules from chemical structures prior to chemical synthesis and fungal assay validation. The model expands Evogene's ChemPass AI for Ag platform and is designed to support AgPlenus' internal fungicide pipeline, including APTF-1 targeting Septoria Wheat Blotch, as well as planned expansions targeting Botrytis and Fusarium pathogens. The global fungicide market is estimated at approximately $22 billion annually, while Evogene currently trades at a market cap of $4.98 million.Stock TitanAgPlenus Launches Antifungal Potency AI ModelAgPlenus Ltd., a subsidiary of Evogene Ltd., has launched its Antifungal Potency Predictor (APP), a new machine learning model that predicts antifungal potency of small molecules directly from chemical structures, expanding the ChemPass AI for Ag™ platform capabilities. The model enables early-stage prediction of biological efficacy prior to chemical synthesis and experimental testing, reducing the number of molecules requiring evaluation and accelerating next-generation fungicide discovery. The launch supports AgPlenus' internal fungicide pipeline targeting diseases like Septoria Wheat Blotch, Botrytis, and Fusarium in a global fungicide market estimated at approximately $22 billion annually.PR NewswireAgPlenus Launches Novel AI Model for Predicting Antifungal Potency, Expanding ChemPass AI for Ag™ CapabilitiesAgPlenus launched its Antifungal Potency Predictor (APP), a machine learning model that predicts antifungal potency from chemical structures. The model expands Evogene's ChemPass AI for Ag platform, aiming to forecast efficacy before synthesis and testing. It supports AgPlenus' internal pipeline, including targets for Septoria wheat blotch and planned expansions for Botrytis and Fusarium.PR NewswireEvogene Reports Second Quarter 2025 Financial ResultsEvogene Ltd. reported second quarter 2025 financial results, with first-half revenues of $3.2 million, up 40% year-over-year driven by higher seed sales from subsidiary Casterra, while operating expenses decreased 31% to $7.7 million and net loss narrowed to $7.7 million from $9.8 million. The company completed the sale of most of Lavie Bio's activities and the MicroBoost AI for Ag platform to ICL for $18.71 million in July 2025, and raised $4.4 million through an at-the-market equity facility in June 2025. Evogene is undertaking a strategic repositioning centered on its ChemPass AI platform, including workforce reductions of 30% at Evogene and 40% at AgPlenus, partnerships with Google Cloud and Tel Aviv University, and an 18-month operational runway.PR NewswireAgPlenus Announces Appointment of Dr. Dan Jacob Gelvan as its Incoming Chief Executive OfficerAgPlenus Ltd., a subsidiary of Evogene Ltd., announced the appointment of Dr. Dan Jacob Gelvan as its new Chief Executive Officer effective February 19, 2024, succeeding Dr. Brian Ember who will transition to the role of Chief Business Officer. Dr. Gelvan brings over three decades of experience in leading science and technology companies within the pharmaceutical, biotech, and healthcare sectors. Ofer Haviv, CEO of Evogene and chairman of AgPlenus, expressed confidence in Dr. Gelvan's ability to guide AgPlenus through its next phase of growth and innovation.PR NewswireAgPlenus to Attend World Agri-Tech Conference in San FranciscoAgPlenus Ltd., an Israeli computational biology company designing crop protection products and a subsidiary of Evogene Ltd., announced that two of its executives will attend and participate at the World Agri-Tech Conference in San Francisco on March 14-15, 2023. The representatives are Merav Beiman, VP R&D, and Mirit Ram, VP Portfolio Management. This is a routine corporate communication announcing conference attendance rather than any specific business development or deal.PR NewswireEvogene to Attend to World Agri-Tech Innovation Summit from March 22-23, 2022Evogene Ltd. announced that it will attend the World Agri-Tech Innovation Summit in San Francisco on March 22-23, 2022. The company's management team, including executives from its subsidiaries Lavie Bio and AgPlenus, will be present to meet with investors. This event serves as a platform for the global agtech ecosystem to exchange insights and identify future partners.PR NewswireAgPlenus Announces Positive Results for a Herbicide Resistance Trait to its Leading Herbicide Product CandidateAgPlenus Ltd., a subsidiary of Evogene Ltd., announced positive results from a Proof of Concept test demonstrating that model plants modified with a resistance trait were resistant to its novel herbicide candidate APH1, while unmodified control plants showed significant damage. The greenhouse tests using transformed tobacco plants sprayed with APH1 at a high dose equivalent to 2 kg/ha showed no harm to modified plants, indicating the feasibility of developing commercial crops resistant to APH1. The company now plans to extend this resistance development to soybean plants, potentially expanding APH1's addressable market beyond the crops like corn and cereals that already exhibit inherent tolerance to the herbicide.